Prognostic significance of heparanase expression in primary and metastatic breast carcinoma
Open Access
- 21 December 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (5) , 6238-6244
Abstract
Prognostic significance of heparanase expression in primary and metastatic breast carcinoma Prognostic significance of heparanase expression in primary and metastatic breast carcinomaKeywords
This publication has 35 references indexed in Scilit:
- Molecular Concordance Between Primary Breast Cancer and Matched MetastasesThe Breast Journal, 2016
- Heparanase Enhances Tumor Growth and Chemoresistance by Promoting AutophagyCancer Research, 2015
- Heparanase enhances myeloma progression via CXCL10 downregulationLeukemia, 2014
- PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical modelsBritish Journal of Cancer, 2011
- Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasisThe FEBS Journal, 2010
- Heparanase: Structure, Biological Functions, and Inhibition by Heparin-Derived Mimetics of Heparan SulfateCurrent Pharmaceutical Design, 2007
- COX-2 induction by heparanase in the progression of breast cancerInternational Journal of Molecular Medicine, 2006
- Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesisThe International Journal of Biochemistry & Cell Biology, 2006
- Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine TherapyJournal of Clinical Oncology, 2005
- Heparanase promotes growth, angiogenesis and survival of primary breast tumorsInternational Journal of Cancer, 2005